PEDOT:PSS thin films: Applications in Bioelectronics

Owing to their capability of merging the properties of metals and conventional polymers, Conducting Polymers (CPs) are a unique class of carbon-based materials capable of conducting electrical current. A conjugated backbone is the hallmark of CPs, which can readily undergo reversible doping to different extents, thus achieving a wide range of electrical conductivities, while maintaining mechanical flexibility, transparency and high thermal stability. Thanks to these inherent versatility and attracting properties, from their discovery CPs have experienced incessant widespread in a great plethora of research fields, ranging from energy storage to healthcare, also encouraging the spring and growth of new scientific areas with highly innovative content. Nowadays, Bioelectronics stands out as one of the most promising research fields, dealing with the mutual interplay between biology and electronics. Among CPs, the polyelectrolyte complex poly (3,4-ethylenedioxythiophene): poly (styrenesulfonate) (PEDOT:PSS), especially in the form of thin films, has been emphasized as ideal platform for bioelectronic applications. Indeed, in the last two decades PEDOT:PSS has played a key role in the sensing of bioanalytes and living cells interfacing and monitoring. In the present work, development and characterization of two kinds of PEDOT:PSS-based devices for applications in Bioelectronics are discussed in detail. In particular, a low-cost amperometric sensor for the selective detection of Dopamine in a ternary mixture was optimized, taking advantage of the electrocatalytic and antifouling properties that render PEDOT:PSS thin films appealing tools for electrochemical sensing of bioanalytes. Moreover, the potentialities of this material to interact with live cells were explored through the fabrication of a microfluidic trapping device for electrical monitoring of 3D spheroids using an impedance-based approach.

Pulse shape studies of neutral particles with a liquid scintillator

The hadrontherapy exploits beams of charged particles against deep cancers. These ions have a depth-dose profile in which there is a little release of energy at the beginning of their path, whereas there is a sharp maximum, the Bragg Peak, near its end path. However, if heavy ions are used, the fragmentation of the projectile can happen and the fragments can release some dose outside the treatment volume beyond the Bragg peak. The fragmentation process takes place also when the Galactic Cosmic Rays at high energy hit the spaceship during space missions. In both cases some neutrons can be produced and if they interact with the absorbing materials nuclei some secondary particles are generated which can release energy. For this reason, studies about the cross section measurements of the fragments generated during the collisions of heavy ions against the tissues nuclei are very important. In this context, the FragmentatiOn Of Target (FOOT) experiment was born, and aims at measuring the differential and double differential fragmentation cross sections for different kinetic energies relevant to hadrontherapy and space radioprotection with high accuracy. Since during fragmentation processes also neutrons are produced, tests of a neutron detection system are ongoing. In particular, recently a neutron detector made up of a liquid organic scintillator, BC-501A with neutrons/gammas discrimination capability was studied, and it represents the core of this thesis. More in details, an analysis of the data collected at the GSI laboratory, in Darmstadt, Germany, is effectuated which consists in discriminating neutral and charged particles and then to separate neutrons from gammas. From this analysis, a preliminary energy-differential reaction cross-section for the production of neutrons in the 16O + (C_2H_4)_(n) and 16O + C reactions was estimated.